Condition
Atypical Depression
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 2 (1)
P 3 (2)
P 4 (1)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07031661Recruiting
A Cohort Study of Disease Prediction Model for High-risk Population With Bipolar Disorder
NCT00477854Not ApplicableCompleted
Effects of Chromium Picolinate on Food Intake
NCT00215176Phase 2CompletedPrimary
Modafinil for Atypical Depression
NCT00610506Phase 3CompletedPrimary
Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
NCT00861978Phase 3CompletedPrimary
St. John's Wort Extract LI 160 for the Treatment of Atypical Depression
NCT00296699Phase 4CompletedPrimary
A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
Showing all 6 trials